01698nam 2200349 450 991068845620332120230630044620.0(CKB)5400000000044771(NjHacI)995400000000044771(EXLCZ)99540000000004477120230630d2021 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierAdvances in Precision Medicine Oncology /Hilal Arnouk, Bassam Hassan, editorLondon :IntechOpen,2021.1 online resource (260 pages)1-83968-869-6 Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects.CancerTreatmentCancerTreatment.616.99406Hassan BassamArnouk HilalNjHacINjHaclBOOK9910688456203321Advances in Precision Medicine Oncology2828415UNINA